-
The Risk-Based Data Management (RBDM) Revolution
Clinical Research News | The clinical trials landscape is evolving with more data, increased investment in personalized medicines and a shift toward decentralized and hybrid clinical trials. At the same time, the industry is attempting to become more efficient and harness new technologies and data science in operations.
May 24, 2024
-
Pan-RAS Inhibitor Offers Hope of Improved Pancreatic Cancer Prognosis
Clinical Research News | A consortium of pancreatic cancer researchers sharing information in real time has shown that an oral pan-RAS inhibitor known as RMC-7977, developed by Revolution Medicines, effectively targets the common cancer-causing RAS proteins while minimally impacting normal cells—and did so across a comprehensive range of preclinical models in a series of similar experiments.
May 22, 2024
-
Brain Stimulation Device Could Make Precision Mental Health A Reality
Clinical Research News | In the not-too-distant future, disorders of the brain could be treated with the same precision as heart disease and cancer. The means will be a therapeutic brain-computer interface (BCI) the size of a small blueberry for people suffering from treatment-resistant depression that uses a similar type of implant technology as Elon Musk’s Neuralink for helping paralyzed people speak.
May 21, 2024
-
Challenges Facing Cell & Gene Therapy Clinical Trials
Clinical Research News | Clinical trials are the bedrock for developing advanced treatments within the life-saving field of cell and gene therapy. Despite significant strides, these trials encounter multi-faceted challenges that threaten to impede the progress of important new therapies.
May 17, 2024
